Congressional News & Analysis

Original reporting on legislation, votes, hearings, lobbying and campaign finance — newest first.

Commerce

Schwab Lobbies to Get in on Crypto

Digital asset lobbying by Charles Schwab intensifies as the firm spends $540K on crypto regulation and electronic disclosure reforms through Q3 2025.

Commerce

Aflac Lobbies on Insurance and Paid Leave

Aflac spent $1.37M on supplemental insurance lobbying in Q3 2025, targeting ACA regulation, paid leave legislation, and military healthcare benefits expansion.

Health

Boston Scientific Spends $570K on Q3 Lobbying Push

Boston Scientific disclosed $570,000 in Q3 2025 lobbying expenditures as part of more than $37 million spent since 2003, focusing on Medicare and Medicaid reimbursement, taxation, trade, and veterans affairs.

Community Development and Housing

National Apartment Association Lobbies on Housing Policy

Overview of the National Apartment Association’s lobbying activity: $680,000 in Q3 2025, $22.2M over 15 years, and active advocacy on housing supply, eviction notices, rental assistance, and tax credits.

Lobbying Activity

Civil Rights Advocacy in a Polarized Congress

Summary of The Leadership Conference on Civil and Human Rights’ Q3 2025 lobbying: $530,000 in-house spend, historical $30.86M total, priorities include the Justice for All Act, voting rights, and responses to executive rollbacks.

Banking, Finance, and Domestic Commerce

Insurance Lobbying Spending: Nationwide’s Q3 2025 Advocacy Push

Nationwide invested $1.26M in Q3 2025 lobbying as part of $67.3M over 20 years, prioritizing NFIP reform, auto insurance regulation, data privacy/AI governance, and federal-state authority amid climate-driven market instability.

Banking, Finance, and Domestic Commerce

PayPal Invests $570K in Q3 Lobbying Push

PayPal reported $570,000 in in-house lobbying for Q3 2025, part of a broader effort exceeding $11.7M since 2015. The company continues to hire specialized firms to influence digital payments, crypto, BNPL, and regulatory policy.